171 related articles for article (PubMed ID: 8448243)
1. On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease.
Carreras E; Grañena A; Navasa M; Bruguera M; Marco V; Sierra J; Tassies MD; García-Pagán JC; Martí JM; Bosch J
Ann Hematol; 1993 Feb; 66(2):77-80. PubMed ID: 8448243
[TBL] [Abstract][Full Text] [Related]
2. Hepatic veno-occlusive disease after bone marrow transplant.
Carreras E; Grañena A; Rozman C
Blood Rev; 1993 Mar; 7(1):43-51. PubMed ID: 8467232
[TBL] [Abstract][Full Text] [Related]
3. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
4. Sonographic diagnosis and hemodynamic correlation in veno-occlusive disease of the liver.
Nicolau C; Brú C; Carreras E; Bosch J; Bianchi L; Gilabert R; Vilana R
J Ultrasound Med; 1993 Aug; 12(8):437-40. PubMed ID: 8411325
[TBL] [Abstract][Full Text] [Related]
5. Transjugular liver biopsy in BMT.
Carreras E; Grañena A; Navasa M; Bruguera M; Marco V; Sierra J; Tassies MD; García-Pagán JC; Martí JM; Bosch J
Bone Marrow Transplant; 1993 Jan; 11(1):21-6. PubMed ID: 8431707
[TBL] [Abstract][Full Text] [Related]
6. Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.
Shulman HM; Hinterberger W
Bone Marrow Transplant; 1992 Sep; 10(3):197-214. PubMed ID: 1422475
[TBL] [Abstract][Full Text] [Related]
7. Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review.
Ravaioli F; Colecchia A; Alemanni LV; Vestito A; Dajti E; Marasco G; Sessa M; Pession A; Bonifazi F; Festi D
Expert Rev Gastroenterol Hepatol; 2019 May; 13(5):463-484. PubMed ID: 30895833
[TBL] [Abstract][Full Text] [Related]
8. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation.
Blostein MD; Paltiel OB; Thibault A; Rybka WB
Bone Marrow Transplant; 1992 Nov; 10(5):439-43. PubMed ID: 1464007
[TBL] [Abstract][Full Text] [Related]
9. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
[TBL] [Abstract][Full Text] [Related]
10. [Veno-occlusive disease of the liver].
Rybicka M; Krysiak R; Okopień B
Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
[TBL] [Abstract][Full Text] [Related]
11. Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF).
Kaleelrahman M; Eaton JD; Leeming D; Bowyer K; Taberner D; Chang J; Scarffe JH; Chopra R
Hematology; 2003 Apr; 8(2):91-5. PubMed ID: 12745658
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation.
Azoulay D; Castaing D; Lemoine A; Hargreaves GM; Bismuth H
Bone Marrow Transplant; 2000 May; 25(9):987-92. PubMed ID: 10800068
[TBL] [Abstract][Full Text] [Related]
13. Veno-occlusive disease of the liver after blood and marrow transplantation: analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator.
Litzow MR; Repoussis PD; Schroeder G; Schembri-Wismayer D; Batts KP; Anderson PM; Arndt CA; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Noël P; Solberg LA; Letendre L; Hoagland HC
Leuk Lymphoma; 2002 Nov; 43(11):2099-107. PubMed ID: 12533034
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation.
Salat C; Holler E; Kolb HJ; Reinhardt B; Pihusch R; Wilmanns W; Hiller E
Blood; 1997 Mar; 89(6):2184-8. PubMed ID: 9058743
[TBL] [Abstract][Full Text] [Related]
15. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.
McDonald GB; Hinds MS; Fisher LD; Schoch HG; Wolford JL; Banaji M; Hardin BJ; Shulman HM; Clift RA
Ann Intern Med; 1993 Feb; 118(4):255-67. PubMed ID: 8420443
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
Rozman C; Carreras E; Qian C; Gale RP; Bortin MM; Rowlings PA; Ash RC; Champlin RE; Henslee-Downey PJ; Herzig RH; Hinterberger W; Klein JP; Prentice HG; Reiffers J; Zwaan FE; Horowitz MM
Bone Marrow Transplant; 1996 Jan; 17(1):75-80. PubMed ID: 8673059
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
Sullivan KM; Kansu E; Storer B; Jocom J; Emerson G; Reagan T; Emerson V; Siadak MF; Davis C; Appelbaum FR; Buckner CD; Hansen JA; Shulman HM; Storb R; McDonald GB
Biol Blood Marrow Transplant; 1998; 4(1):20-6. PubMed ID: 9701388
[TBL] [Abstract][Full Text] [Related]
18. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.
Rapoport AP; Doyle HR; Starzl T; Rowe JM; Doeblin T; DiPersio JF
Bone Marrow Transplant; 1991 Nov; 8(5):421-4. PubMed ID: 1768978
[TBL] [Abstract][Full Text] [Related]
19. Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan/cyclophosphamide preparative regimen.
Brodsky R; Topolsky D; Crilley P; Bulova S; Brodsky I
Am J Clin Oncol; 1990 Jun; 13(3):221-5. PubMed ID: 2346127
[TBL] [Abstract][Full Text] [Related]
20. Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
Lee JH; Lee KH; Choi JS; Zang DY; Kim SB; Kim SW; Suh C; Lee JS; Kim WK; Lee YS; Kim SH
J Korean Med Sci; 1996 Apr; 11(2):118-26. PubMed ID: 8835758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
